美康生物：关于控股子公司取得医疗器械注册证的公告

Group 1 - The core point of the article is that Meikang Bio has announced that its subsidiary, Jiangxi Meikang Shengde Biotechnology Co., Ltd., has obtained a medical device registration certificate for in vitro diagnostic reagents from the Jiangxi Provincial Drug Administration [2] Group 2 - The registration certificate is a significant regulatory approval that may enhance the company's product offerings in the medical device sector [2] - This development indicates the company's ongoing efforts to expand its presence in the biotechnology industry [2] - The approval could potentially lead to increased revenue opportunities for the company through the commercialization of its diagnostic products [2]